Provided by Tiger Trade Technology Pte. Ltd.

NEURIZON THERAPEUTICS LTD

0.080
-0.001-1.23%
Volume:1.06M
Turnover:85.16K
Market Cap:56.65M
PE:-2.71
High:0.082
Open:0.080
Low:0.080
Close:0.081
52wk High:0.185
52wk Low:0.076
Shares:708.13M
Float Shares:351.37M
Volume Ratio:2.88
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.030
EPS(LYR):-0.034
ROE:-147.09%
ROA:-60.21%
PB:6.84
PE(LYR):-2.35

Loading ...

Company Profile

Company Name:
NEURIZON THERAPEUTICS LTD
Exchange:
ASX
Establishment Date:
2000
Employees:
4
Office Location:
Suite 2,Level 11,385 Bourke Street,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
- -
Introduction:
PharmAust Limited operates as a drug discovery and development company in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. PharmAust Limited is based in Bentley, Australia.